| Name |
Recombinant Human BTNL8 Fc Chimera Protein, CF
|
| Supplier |
R&D Systems
|
| Catalog |
9359-BT
|
| Category |
Protein
|
| Prices |
$329.00
|
| Sizes |
50 µg
|
| Species Reactivities |
Human
|
| Nature |
Recombinant
|
| Source |
Human embryonic kidney cell, HEK293-derived Human BTNL8 (Gln18-Lys238) Accession # Q6UX41-1 IEGRMD Human IgG 1 (Pro100-Lys330) N-terminus C-terminus
|
| Purity |
>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
|
| Bioactivity |
Meassure by its ability to enhance anti-CD3-induced IFN-gamma secretion of mouse CD3 + T cells. The ED 50 for this effect is 0.5-2.5 μg/mL.
|
| Endotoxin |
<0.10 EU per 1 μg of the protein by the LAL method.
|
| SwissProt/Accession |
Q6UX41-1
|
| Gene |
BTNL8
|
| Sequence |
No results obtained. Gln18 inferred from enzymatic pyroglutamate treatment revealing Trp19
|
| Supplier Page |
Shop
|
Recombinant Human BTNL8 Fc Chimera (Catalog # 9359-BT)enhances anti-CD3-induced IFN-gamma secretion by mouse CD3 + T cells. The ED 50 forthis effect is 0.5-2.5 μg/mL.